Trial Information

If you have RA and have had an inadequate response to a TNF-a inhibitor, contact us today!

The purpose of this research study is to find out the effectiveness and safety of 2 different doses of a new study drug in subjects with RA who have had an inadequate response to a TNF-a inhibitor.

Patient Inclusion Criteria:

Males or females =18 years of age.
Diagnosis of adult-onset RA of at least 6 months
Patients must have been treated at approved doses with at least one biologic TNF-a inhibitor therapy
Regular use of at least one conventional DMARD
Women must not be pregnant, breastfeeding, or at risk to become pregnant during study participation.

Patient Exclusion Criteria:

Have had surgical treatment within 60 days of a joint that is to be assessed in the study or will require such treatment during the study.
Have had any major surgery within 60 days, or will require such during the study.
Have active fibromyalgia or have a diagnosis of any systemic inflammatory condition other than RA
Have had any malignancy within the past 5 years, except for cervical carcinoma in situ that has been resected with no evidence of recurrence or metastatic disease, or basal cell or squamous epithelial skin cancers that were completely resected and have no evidence of recurrence for at least three years.
Are positive for human immunodeficiency virus (HIV).
Have had a serious infection (e.g., pneumonia, cellulitis) within 3 months of baselineor had serious bone or joint infections within 6 months
Have an active or recent infection (including symptomatic herpes zoster or herpes simplex) within 30 days
Have evidence of active or latent tuberculosis (TB) as documented by a positive PPD test

Paul Koros, RN, Site Manager
NEA Baptist Clinic - Clinical Research Center
416 E. Washington, Suite C
Jonesboro, AR 72401
Phone: 870-934-1006
Fax: 870-934-1008
Email: paul.koros@neabaptistclinic.com

View Map

Research Center Information: NEA Baptist Clinic - Clinical Research Center

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:
Message:

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.